# Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Ketamine

> **NCT03621085** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 43 (actual)

## Conditions studied

- Hemorrhage
- Healthy

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03621085
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2021-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03621085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03621085, "Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Ketamine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03621085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*